DE Jorenby, JT Hays, NA Rigotti, S Azoulay, … - Jama, 2006 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Varenicline, a ... Cited by 338 - Related articles - BL Direct - All 16 versions
S Tonstad, P Tonnesen, P Hajek, KE Williams, … - Jama, 2006 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context The majority of ... Cited by 303 - Related articles - BL Direct - All 14 versions
- ►oxfordjournals.org S Tonstad, C Farsang, G Klaene, K Lewis, A … - European heart journal, 2003 - Eur Soc Cardiology Methods Six hundred twenty-nine subjects with CVD who smoked 10 cigarettes/day
were randomised in a double-blind, multicentre study to receive bupropion SR
(150mg twice daily) or placebo for 7 weeks, with a follow-up of 52 weeks. ... Cited by 132 - Related articles - BL Direct - All 6 versions
C Filozof, MC Fernandez Pinilla, A Fernandez … - Obesity Reviews, 2004 - interscience.wiley.com Cigarette smoking is the single most important preventable cause of death and
illness. Smoking cessation is associated with substantial health benefits.
Weight gain is cited as a primary reason for not trying to quit smoking. ... Cited by 112 - Related articles - BL Direct - All 3 versions
- ►cell.com TP George, SS O'Malley - Trends in Pharmacological Sciences, 2004 - Elsevier There are nearly 1.1 billion users of nicotine and tobacco products worldwide.
Tobacco use through cigarette smoking is the leading preventable cause of death
in the world and kills nearly four million people annually. However, ... Cited by 92 - Related articles - All 13 versions
P Tonnesen, S Tonstad, A Hjalmarson, F … - Journal of internal medicine, 2003 - interscience.wiley.com Abstract. Tønnesen P, Tonstad S, Hjalmarson A, Lebargy F, van Spiegel PI, Hider
A, Sweet R, Townsend J (Gentofte University Hospital, Gentofte, Denmark; Clinic
for Preventive Medicine, Ullevål University Hospital, Oslo, Norway; ... Cited by 88 - Related articles - BL Direct - All 4 versions
- ►psychiatryonline.org SM Hall, GL Humfleet, VI Reus, RF Munoz, J … - American Journal of Psychiatry, 2004 - Am Psychiatric Assoc OBJECTIVE: Accepted treatments for cigarette smoking rarely achieve abstinence
rates of >35% at 1 year. Low rates may reflect failure to provide extended and
multifocal treatment for this complex and chronic addiction. Using a ... Cited by 85 - Related articles - BL Direct - All 11 versions
- ►tern.org [PDF] R Niaura, DB Abrams - Journal of Consulting and Clinical Psychology, 2002 - psycnet.apa.org The authors review developments in understanding smoking cessation interventions
over the past decade. Noteworthy is the unprecedented growth of research and
knowledge that has left a deeper understanding of how best to use new and ... Cited by 82 - Related articles - BL Direct - All 11 versions
- ►ersj.org.uk P Tonnesen, L Carrozzi, KO Fagerstrom, C … - European Respiratory Journal, 2007 - ersj.org.uk 1 Dept of Pulmonary Medicine, Gentofte Hospital, Copenhagen, Denmark, 2
Cardiopulmonary Dept, University Hospital of Pisa, and 7 Pulmonary Environmental
Epidemiology Unit, CNR Institute of Clinical Physiology, Pisa, and 6 ... Cited by 79 - Related articles - BL Direct - All 8 versions
JF Cryan, AW Bruijnzeel, KL Skjei, A Markou - Psychopharmacology, 2003 - Springer Abstract Rationale: Bupropion is an atypical antidepres- sant and the only
non-nicotine-based therapy approved for smoking cessation. Its use has raised
much debate as to how a non-nicotine-based agent can aid in smoking ... Cited by 75 - Related articles - BL Direct - All 4 versions
